Table 3.
Relative sensitivity and specificity of the OncoPredict HPV® SCR compared to GP 5+/6+ PCR‐EIA
Comparison | Outcome | Relative accuracy (95% CI) | p Mcn | p n.inf |
---|---|---|---|---|
Total study population | ||||
Relative sensitivity | CIN2+ | 1.01 (0.99–1.03) | 1.000 | <0.0005 |
Relative sensitivity | CIN3+ | 1.00 (0.96–1.03) | 1.000 | 0.0098 |
Relative specificity | ≤CIN1 | 1.02 (1.00–1.04) | 0.164 | 0.0004 |
Women ≥ 30 years | ||||
Relative sensitivity | CIN2+ | 1.00 (0.95–1.05) | 1.000 | 0.0187 |
Relative sensitivity | CIN3+ | 1.00 (0.92–1.09) | 1.000 | 0.0633 |
Relative specificity | ≤CIN1 | 1.01 (0.99–1.03) | 0.377 | 0.0021 |
Abbreviation: HPV, human papillomavirus.